MPOWERED: STUDY DESIGN OF A PHASE 3 HEAD-TO-HEAD TRIAL EVALUATING ORAL OCTREOTIDE CAPSULES VERSUS INJECTABLE SOMATOSTATIN ANALOGS IN PATIENTS WITH ACROMEGALY
AACE ePoster Library. Fleseriu M. 05/27/16; 131504; 938
Disclosure(s): Fleseriu: Has been a principal investigator in clinical trials sponsored by Chiasma Pharmaceuticals, Cortendo, Ipsen, Novartis and Pfizer, with research support provided to Oregon Health & Science University (OHSU). She also has been an ad- hoc consultant for Chiasma, Cortendo, Novartis and Pfizer; Katznelson: Principal investigator on clinical trials supported by Novartis and Chiasma; Clemmons: Consulted for Chiasma; Trainer: Research Support for clinical studies: Novartis, Antisense Therapeutics, Cortendo, Versartis, Ipsen; Biermasz: Has been a principal investigator in clinical trials sponsored by Chiasma Pharmaceuticals and Ipsen and received research support from the Dutch Research Council. She also has been an ad- hoc consultant for Chiasma and Pfizer; Strasburger: Received consulting honoraria and speaker's fees from Chiasma, Pfizer, Ipsen and Novartis; Haviv: Chiasma employee; Patou: Chiasma employee; Melmed: Serves as a scientific consultant for Chiasma and ISIS Pharmaceuticals, as an educational consultant for Novartis, and has received research grants from Ipsen and Pfizer
Dr. Maria Fleseriu
REGULAR CONTENT
Login now to access Regular content available to all registered users.
Rate & Comment (0)
{{ help_message }}
{{filter}}